Home » Topics » Regulatory

Regulatory
RSS

Colesevelam heads for first market launch

July 18, 2000

The former Warner-Lambert claims use of MEK kinase inhibitors for transplant rejection

July 17, 2000

Santarus initiates phase II trial of delayed-release azathioprine for treatment of Crohn's disease

July 17, 2000

LMWH such as enoxaparin claimed for use in motor neuron diseases

July 17, 2000

New formulations of RenaGel approved for use by FDA

July 17, 2000

FDA advisory committee recommends against approval of OTC Mevacor

July 17, 2000

Aventis discovers utility of riluzole in hearing disorders

July 14, 2000

Arthritis Advisory Committee recommends new approval for Remicade

July 13, 2000

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

July 11, 2000

Tamoxifen for DCIS granted FDA approval

July 10, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...